Nan Fung and Lam Research are set to exit the DNA sequencing technology developer in an $800m acquisition by market peer Pacific Biosciences.

Insight Partners and Tiger Global Management co-led a series C round valuing the Google, Slack and Intel-backed collaboration software provider above $2bn.

6 Dimensions Capital-backed neuromodulation technology developer Neuspera closed a $65m round while gene therapy developer Coave Therapeutics hiked its latest round to $39m.

SoftBank, Circle and Coinbase Ventures were among more than 60 investors which funded the crypto exchange operator at an $18bn valuation.

Red Ventures has made a strategic investment in Tilting Point as part of the video game publishers’ first equity funding round.

Intel Capital co-led the artificial intelligence chip developer's latest round with Tracker Capital Management, taking its total funding past $145m.

Access Biotechnology is in line for an exit after the neuronal excitability disorder drug developer filed to float on the Nasdaq Global Market.

Telefónica-backed addiction treatment app developer Quit Genius raised $64m while oral care product maker NYSCPS received almost as much in a round featuring ByteDance.

Several corporates helped the Montana State University-backed microbial protein developer take its total funding above $500m.

The UChicago-backed digital home insurance provider is joining forces with Omnichannel Acquisition Corp at a valuation of just over $1bn.